175 related articles for article (PubMed ID: 16523013)
1. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
Mahmud SM; Tanguay S; Bégin LR; Franco EL; Aprikian AG
Eur J Cancer Prev; 2006 Apr; 15(2):158-64. PubMed ID: 16523013
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
3. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
4. Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence.
Dasgupta K; Di Cesar D; Ghosn J; Rajan R; Mahmud S; Rahme E
Cancer J; 2006; 12(2):130-5. PubMed ID: 16630404
[TBL] [Abstract][Full Text] [Related]
5. Aspirin use in relation to risk of prostate cancer.
Leitzmann MF; Stampfer MJ; Ma J; Chan JM; Colditz GA; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1108-11. PubMed ID: 12376516
[TBL] [Abstract][Full Text] [Related]
6. Regular use of aspirin and prostate cancer risk (United States).
Menezes RJ; Swede H; Niles R; Moysich KB
Cancer Causes Control; 2006 Apr; 17(3):251-6. PubMed ID: 16489532
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
[TBL] [Abstract][Full Text] [Related]
8. Association between coronary heart disease and cancers of the breast, prostate, and colon.
Neugut AI; Rosenberg DJ; Ahsan H; Jacobson JS; Wahid N; Hagan M; Rahman MI; Khan ZR; Chen L; Pablos-Mendez A; Shea S
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):869-73. PubMed ID: 9796631
[TBL] [Abstract][Full Text] [Related]
9. Effects of non-selective non-steroidal anti-inflammatory drugs on the aggressiveness of prostate cancer.
Stock DC; Groome PA; Siemens DR; Rohland SL; Song Z
Prostate; 2008 Nov; 68(15):1655-65. PubMed ID: 18698582
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
Peleg II; Maibach HT; Brown SH; Wilcox CM
Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
[TBL] [Abstract][Full Text] [Related]
11. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
12. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
Thompson IM; Pauler Ankerst D; Chi C; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
J Clin Oncol; 2007 Jul; 25(21):3076-81. PubMed ID: 17634486
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers.
Harris RE; Beebe-Donk J; Schuller HM
Oncol Rep; 2002; 9(4):693-5. PubMed ID: 12066194
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha.
Liu X; Plummer SJ; Nock NL; Casey G; Witte JS
Am J Epidemiol; 2006 Nov; 164(10):984-9. PubMed ID: 16931544
[TBL] [Abstract][Full Text] [Related]
15. Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China.
Liu E; Sakoda LC; Gao YT; Rashid A; Shen MC; Wang BS; Deng J; Han TQ; Zhang BH; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1315-8. PubMed ID: 15894693
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer.
Roberts RO; Jacobson DJ; Girman CJ; Rhodes T; Lieber MM; Jacobsen SJ
Mayo Clin Proc; 2002 Mar; 77(3):219-25. PubMed ID: 11888024
[TBL] [Abstract][Full Text] [Related]
17. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
18. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
[TBL] [Abstract][Full Text] [Related]
19. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
Cohen YC; Liu KS; Heyden NL; Carides AD; Anderson KM; Daifotis AG; Gann PH
J Natl Cancer Inst; 2007 Sep; 99(18):1366-74. PubMed ID: 17848668
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs.
Chan JM; Feraco A; Shuman M; Hernández-Díaz S
Hematol Oncol Clin North Am; 2006 Aug; 20(4):797-809. PubMed ID: 16861115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
